<DOC>
	<DOCNO>NCT01300650</DOCNO>
	<brief_summary>This open-label , non-randomized , pilot-study evaluate effect Interleukin-1 blockade exercise capacity patient heart failure . Subjects undergo cardiopulmonary exercise test baseline 2-weeks treatment anakinra ( recombinant human Interleukin-1 receptor antagonist ) .</brief_summary>
	<brief_title>Pilot Study Safety Efficacy Anakinra ( Recombinant Human Interleukin-1 Receptor Antagonist ) Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<criteria>Confirmed diagnosis heart failure Recent echocardiogram documenting leave ventricular ejection fraction &lt; 40 % High sensitivity Creactive protein &gt; 2 mg/L . Recent change ( previous 3 month ) HF maintenance medication ( betablockers , angiotensin convert enzyme [ ACE ] inhibitor , aldosterone antagonist , vasodilator , cardiac glycoside , diuretic ) Hospitalization worsen HF acute decompensated HF within previous 12 month Anticipated need cardiac resynchronization therapy ( CRT ) automatedimplantable cardioverter defibrillator ( AICD ) Angina electrocardiograph ( ECG ) change limit maximum exertion cardiopulmonary exercise test baseline ECG change limit ability detect ischemia ( i.e . leave bundlebranch block ) . Recent ( &lt; 14 day ) use antiinflammatory drug ( include NSAIDs ) , chronic inflammatory disorder ( include limit rheumatoid arthritis , systemic lupus erythematosus ) , malignancy , active infection , comorbidity limit survival ability complete study Severe kidney dysfunction ( eGFR &lt; 30 mL/min ) Coagulopathy ( INR &gt; 1.5 ) , thrombocytopenia ( &lt; 50,000/mm3 ) , leukopenia ( absolute neutrophil count &lt; 1,500/mm3 ) Pregnancy ( female patient require take urine pregnancy test ) Latex rubber allergy Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Interleukin-1</keyword>
	<keyword>Cardiopulmonary exercise</keyword>
</DOC>